Brenda M. Sandmaier, M.D., Named ASTCT 2022-2023 President
April 26, 2022 09:00 ET
|
American Society for Transplantation and Cellular Therapy
CHICAGO, April 26, 2022 (GLOBE NEWSWIRE) -- American Society for Transplantation and Cellular Therapy (ASTCT) announced Brenda M. Sandmaier, M.D., as the ASTCT President in 2022-2023. Dr....
Global Immune Checkpoint Inhibitors Market to 2027 - Size, Share & Industry Trends Analysis Report
April 26, 2022 06:43 ET
|
Research and Markets
Dublin, April 26, 2022 (GLOBE NEWSWIRE) -- The "Global Immune Checkpoint Inhibitors Market Size, Share & Industry Trends Analysis Report By Application (Lung Cancer, Bladder Cancer, Melanoma,...
Tessa Therapeutics Appoints Wilson W. Cheung as Chief Financial Officer
April 04, 2022 06:00 ET
|
Tessa Therapeutics Ltd
SINGAPORE, April 04, 2022 (GLOBE NEWSWIRE) -- Tessa Therapeutics Ltd. (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and...
Tessa Therapeutics Showcases Positive Clinical Data from Phase 1 Study of “Off the Shelf” CD30 Cell Therapy at 2021 Annual Meeting of American Society of Hematology (ASH)
December 11, 2021 18:00 ET
|
Tessa Therapeutics Ltd
Oral poster presentation highlights data from dose-escalation trial of allogeneic CD30.CAR EBVST cell therapy (TT11X) in patients with relapsed or refractory CD30-positive lymphomas Results...
Global Diffuse Large B-cell Lymphoma (DLBCL) Competitive Landscape 2021
December 03, 2021 04:23 ET
|
Research and Markets
Dublin, Dec. 03, 2021 (GLOBE NEWSWIRE) -- The "Diffuse Large B-cell Lymphoma (DLBCL) - Competitive Landscape in 2021" report has been added to ResearchAndMarkets.com's offering.The "Diffuse Large...
Tyrokinse Kinase Inhibitors in the Global Oncology Market 2021: Market Leaders by Indication and Product
November 05, 2021 05:58 ET
|
Research and Markets
Dublin, Nov. 05, 2021 (GLOBE NEWSWIRE) -- The "Oncology Markets for Tyrokinse Kinase Inhibitors" report has been added to ResearchAndMarkets.com's offering. Traditional cancer therapy has focused...
Zai Lab Announces First Patient Treated in Greater China Portion of Potentially Registrational, Global Phase 2 Study of Odronextamab
October 25, 2021 07:30 ET
|
Zai Lab Limited
SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, global...
Global Chronic Lymphocytic Leukemia (CLL) Disorder Clinical Market Report 2021-2027
July 06, 2021 08:08 ET
|
Research and Markets
Dublin, July 06, 2021 (GLOBE NEWSWIRE) -- The "Chronic Lymphocytic Leukemia (CLL)" report has been added to ResearchAndMarkets.com's offering. Chronic lymphocytic leukemia (CLL) is a disorder where...
Global Mantle Cell Lymphoma Clinical Landscape Market Report 2021: J&J has the Highest Number of Completed Clinical Trials with 15
June 21, 2021 04:38 ET
|
Research and Markets
Dublin, June 21, 2021 (GLOBE NEWSWIRE) -- The "Market Spotlight: Mantle Cell Lymphoma" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the Mantle Cell...
Global Cutaneous T-Cell Lymphoma (CTCL) Clinical Landscape Market 2021-2031: Treatments, Epidemiology, Marketed Drugs, Pipeline, Regulatory Events, Revenue Opportunity
June 16, 2021 05:03 ET
|
Research and Markets
Dublin, June 16, 2021 (GLOBE NEWSWIRE) -- The "Market Spotlight: Cutaneous T-Cell Lymphoma (CTCL)" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the...